The clinical effectiveness of insulin glargine in patients with Type i diabetes in Brazil: Findings and implications

Lays P. Marra; Vânia E. Araújo; Gerusa C.C. Oliveira; Leonardo M. Diniz; Augusto A. Guerra; Francisco De Assis Acurcio; Brian Godman; Juliana Álvares

doi:10.2217/cer-2016-0099

The clinical effectiveness of insulin glargine in patients with Type i diabetes in Brazil: Findings and implications

Lays P. Marra
, Vânia E. Araújo
, Gerusa C.C. Oliveira
, Leonardo M. Diniz
, Augusto A. Guerra
, Francisco De Assis Acurcio
, Brian Godman
, Juliana Álvares

Universidade Federal de Minas Gerais
University of Strathclyde
Karolinska Institutet
University of Liverpool

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Abstract

Published studies have challenged the cost-effectiveness of insulin glargine versus neutral protamine hagedorn (NPH) insulins in Brazil with limited evidence of increased effectiveness despite considerably higher acquisition costs. However, still a controversy. Consequently, there is a need to address this. Materials & methods: Retrospective cohort study of Type I diabetes patients receiving insulin glargine in Brazil following NPH insulin who met the criteria.

Original language	English
Pages (from-to)	519-527
Number of pages	9
Journal	Future Virology
Volume	12
Issue number	9
DOIs	https://doi.org/10.2217/cer-2016-0099
State	Published - 2017
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Brazil
Comparative effectiveness research
Insulin glargine
Longitudinal studies
NPH insulin
Type I diabetes

Access to Document

10.2217/cer-2016-0099

Cite this

@article{20503374e8184804a5e30b485b55cd67,

title = "The clinical effectiveness of insulin glargine in patients with Type i diabetes in Brazil: Findings and implications",

abstract = "Published studies have challenged the cost-effectiveness of insulin glargine versus neutral protamine hagedorn (NPH) insulins in Brazil with limited evidence of increased effectiveness despite considerably higher acquisition costs. However, still a controversy. Consequently, there is a need to address this. Materials \& methods: Retrospective cohort study of Type I diabetes patients receiving insulin glargine in Brazil following NPH insulin who met the criteria.",

keywords = "Brazil, Comparative effectiveness research, Insulin glargine, Longitudinal studies, NPH insulin, Type I diabetes",

author = "Marra, \{Lays P.\} and Ara{\'u}jo, \{V{\^a}nia E.\} and Oliveira, \{Gerusa C.C.\} and Diniz, \{Leonardo M.\} and Guerra, \{Augusto A.\} and \{De Assis Acurcio\}, Francisco and Brian Godman and Juliana {\'A}lvares",

note = "Publisher Copyright: {\textcopyright} 2017 Future Medicine Ltd.",

year = "2017",

doi = "10.2217/cer-2016-0099",

language = "English",

volume = "12",

pages = "519--527",

journal = "Future Virology",

issn = "1746-0794",

publisher = "Taylor and Francis Ltd.",

number = "9",

}

TY - JOUR

T1 - The clinical effectiveness of insulin glargine in patients with Type i diabetes in Brazil

T2 - Findings and implications

AU - Marra, Lays P.

AU - Araújo, Vânia E.

AU - Oliveira, Gerusa C.C.

AU - Diniz, Leonardo M.

AU - Guerra, Augusto A.

AU - De Assis Acurcio, Francisco

AU - Godman, Brian

AU - Álvares, Juliana

PY - 2017

Y1 - 2017

N2 - Published studies have challenged the cost-effectiveness of insulin glargine versus neutral protamine hagedorn (NPH) insulins in Brazil with limited evidence of increased effectiveness despite considerably higher acquisition costs. However, still a controversy. Consequently, there is a need to address this. Materials & methods: Retrospective cohort study of Type I diabetes patients receiving insulin glargine in Brazil following NPH insulin who met the criteria.

AB - Published studies have challenged the cost-effectiveness of insulin glargine versus neutral protamine hagedorn (NPH) insulins in Brazil with limited evidence of increased effectiveness despite considerably higher acquisition costs. However, still a controversy. Consequently, there is a need to address this. Materials & methods: Retrospective cohort study of Type I diabetes patients receiving insulin glargine in Brazil following NPH insulin who met the criteria.

KW - Brazil

KW - Comparative effectiveness research

KW - Insulin glargine

KW - Longitudinal studies

KW - NPH insulin

KW - Type I diabetes

UR - https://www.scopus.com/pages/publications/85032725038

U2 - 10.2217/cer-2016-0099

DO - 10.2217/cer-2016-0099

M3 - Article

C2 - 28960085

AN - SCOPUS:85032725038

SN - 1746-0794

VL - 12

SP - 519

EP - 527

JO - Future Virology

JF - Future Virology

IS - 9

ER -

The clinical effectiveness of insulin glargine in patients with Type i diabetes in Brazil: Findings and implications

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this